相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Voxelwise Principal Component Analysis of Dynamic [S-Methyl-11C]Methionine PET Data in Glioma Patients
Corentin Martens et al.
CANCERS (2021)
Use of PET Imaging in Neuro-Oncological Surgery
Adrien Holzgreve et al.
CANCERS (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET
Elena K. Bauer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Use of static and dynamic [18F]-F-DOPA PET parameters for detecting patients with glioma recurrence or progression
Timothee Zaragori et al.
EJNMMI RESEARCH (2020)
Volumetric assessment of glioblastoma and its predictive value for survival
Christian Henker et al.
ACTA NEUROCHIRURGICA (2019)
Diagnostic Performance and Prognostic Value of PET/CT with Different Tracers for Brain Tumors: A Systematic Review of Published Meta-Analyses
Giorgio Treglia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Adverse prognosis of glioblastoma contacting the subventricular zone: Biological correlates
Sharon Berendsen et al.
PLOS ONE (2019)
Comparisons Between PET With 11C-Methyl-l-Methionine and Arterial Spin Labeling Perfusion Imaging in Recurrent Glioblastomas Treated With Bevacizumab
Takaaki Beppu et al.
CLINICAL NUCLEAR MEDICINE (2019)
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
Ian Law et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Prognostic Value of MTV, SUVmax and the T/N Ratio of PET/CT in Patients with Glioma: A Systematic Review and Meta-Analysis
Qing Zhang et al.
JOURNAL OF CANCER (2019)
Visual and semiquantitative C-11-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naive gliomas
Nina Poetsch et al.
NEURO-ONCOLOGY (2018)
Prognostic Value of the Metabolic and Volumetric Parameters of 11C-Methionine Positron-Emission Tomography for Gliomas: A Systematic Review and Meta-Analysis
Y. -i. Kim et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2018)
Characteristics of time-activity curves obtained from dynamic C-11-methionine PET in common primary brain tumors
Yuichi Nomura et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Accuracy of 18F-FDOPA Positron Emission Tomography and 18F-FETPositron Emission Tomography for Differentiating Radiation Necrosis from Brain Tumor Recurrence
Jun Yu et al.
WORLD NEUROSURGERY (2018)
Role of amino-acid PET in high-grade gliomas: limitations and perspectives
Antoine Verger et al.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Prognostic value of post-treatment metabolic tumor volume from 11C-methionine PET/CT in recurrent malignant glioma
Tae-Young Jung et al.
NEUROSURGICAL REVIEW (2017)
18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?
Daniel F. Fleischmann et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Estimating progression-free survival in patients with glioblastoma using routinely collected data
Charlotte Kelly et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape
Benjamin M. Ellingson et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
Michael Weller et al.
LANCET ONCOLOGY (2017)
Brain Tumors: An Update on Clinical PET Research in Gliomas
Karl Herholz
SEMINARS IN NUCLEAR MEDICINE (2017)
The performance of 11C-Methionine PET in the differential diagnosis of glioma recurrence
Weilin Xu et al.
ONCOTARGET (2017)
Diagnostic and Prognostic Value of 11C-Methionine PET for Nonenhancing Gliomas
K. Takano et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Maximizing safe resection of low- and high-grade glioma
Shawn L. Hervey-Jumper et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Nathalie L. Albert et al.
NEURO-ONCOLOGY (2016)
Dynamic study of methionine positron emission tomography in patients with glioblastoma with oligodendroglial components
Hirohito Yano et al.
BRAIN TUMOR PATHOLOGY (2015)
The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma
Norbert Galldiks et al.
NEURO-ONCOLOGY (2015)
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM
Bogdana Suchorska et al.
NEUROLOGY (2015)
Diagnostic performance of PET/CT with tracers other than F-18-FDG in oncology: an evidence-based review
G. Treglia et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma
Matthew M. Grabowski et al.
JOURNAL OF NEUROSURGERY (2014)
Dynamic 18F-FET PET in Newly Diagnosed Astrocytic Low-Grade Glioma Identifies High-Risk Patients
Nathalie L. Jansen et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients
Ken Herrmann et al.
NEURO-ONCOLOGY (2014)
Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients
Maximilian Niyazi et al.
RADIATION ONCOLOGY (2014)
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT
Sellam Karunanithi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma
Markus Hutterer et al.
NEURO-ONCOLOGY (2013)
Evaluation of brain tumors using dynamic 11C-methionine-PET
Tatsuki Aki et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Volumetry of [11C]-Methionine Positron Emission Tomographic Uptake as a Prognostic Marker before Treatment of Patients with Malignant Glioma
Norbert Galldiks et al.
MOLECULAR IMAGING (2012)
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for Glioma Grading Assessment of Individual Probability of Malignancy
Maria Lucia Calcagni et al.
CLINICAL NUCLEAR MEDICINE (2011)
Molecular imaging of gliomas with PET: Opportunities and limitations
Christian la Fougere et al.
NEURO-ONCOLOGY (2011)
PET and SPECT Studies of Brian Tumors with Radiolabeled Amino Acids
K. -J Langen et al.
NUKLEARMEDIZIN-NUCLEAR MEDICINE (2011)
PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed
Benjamin D. Klaesner et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Contributions of biological tumor parameters to the incorporation rate of l-[methyl-11C] methionine into astrocytomas and oligodendrogliomas
Takeko Nojiri et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
PET radiotracers: crossing the blood-brain barrier and surviving metabolism
Victor W. Pike
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography
T. Kato et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
Kathleen R. Lamborn et al.
NEURO-ONCOLOGY (2008)
Non-invasive grading of brain tumours using dynamic amino acid PET imaging:: does it work for 11C-Methionine?
Gerard Moulin-Romsee et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas
K Torii et al.
ANNALS OF NUCLEAR MEDICINE (2005)
Direct comparison of F-18-FDG and C-11-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value
K Van Laere et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Methyl-[11C]-L-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma
LW Kracht et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET
JK Chung et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Positron emission tomography with injection of methionine as a prognostic factor in glioma
O De Witte et al.
JOURNAL OF NEUROSURGERY (2001)
分享论文
